Mylan Wants Out Of Investor Suit Over FDA Inspections
Pharmaceutical company Mylan NV told a Pennsylvania federal judge Tuesday he should toss a proposed class action alleging securities fraud because the company made "unvarnished disclosures" about its quality assurance and...To view the full article, register now.
Already a subscriber? Click here to view full article